Turing Pharmaceuticals CEO defends Daraprim price hike ...Middle East

CBS News - Cultural
Turing Pharmaceuticals CEO defends Daraprim price hike
When Turing Pharmaceuticals bought a 62-year-old drug called Daraprim in August, the company immediately raised the price of one pill from $13.50 to $750. The increase drew protests in the medical community from those concerned that many patients will no longer be able to afford the drug. Don Dahler spoke to Turing CEO Martin Shkreli, who says the move is simply a smart business decision.

Hence then, the article about turing pharmaceuticals ceo defends daraprim price hike was published today ( ) and is available on CBS News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Turing Pharmaceuticals CEO defends Daraprim price hike )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Cultural


Latest News